N-m-Aminophenylsuccinimid | 31036-67-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: N-m-Aminophenylsuccinimid
• 英文别名: N-(3-amino-phenyl)-succinimide；N-(3-Amino-phenyl)-succinimid；1-(3-Aminophenyl)pyrrolidine-2,5-dione
• CAS: 31036-67-6
• 化学式: C₁₀H₁₀N₂O₂
• mdl: MFCD11052202
• 分子量: 190.202
• InChiKey: ZUQYKUSMPKOYEC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  63.4
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT

反应信息

• 作为产物：
  描述：

  1-(3-硝基苯基)吡咯烷-2,5-二酮 在 铁粉 、 溶剂黄146 、 丙酮 作用下， 生成 N-m-Aminophenylsuccinimid
  参考文献：
  名称：

  Meyer,R.; Maier,J., Justus Liebigs Annalen der Chemie, 1903, vol. 327, p. 41

  摘要：

  DOI：

文献信息

• [EN] NEW HETEROCYCLIC AMIDE COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] NOUVEAUX COMPOSES AMIDES HETEROCYCLIQUES UTILISES POUR LE TRAITEMENT D'AFFECTIONS INFLAMMATOIRES ET ALLERGIQUES; PROCEDE PERMETTANT DE LES FABRIQUER ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
  申请人：GLENMARK PHARMACEUTICALS LTD

  公开号：WO2004022536A1

  公开（公告）日：2004-03-18

  The present invention relates to novel heterocyclic compounds that inhibit phosphodiesterase type 4 (PDE 4). The compounds are useful for treating inflammatory conditions, diseases of the central nervous systems and insulin resistant diabetes.

  本发明涉及一种新型杂环化合物，可抑制磷酸二酯酶4型（PDE 4）。这些化合物可用于治疗炎症性疾病、中枢神经系统疾病和胰岛素抵抗性糖尿病。
• Heterobicyclic derivatives
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：US20020107251A1

  公开（公告）日：2002-08-08

  Heterobicyclic derivatives of the formula: 1 wherein R 1 is aryl which may have suitable substituent(s), ar(lower)alkyl which may have suitable substituent(s), halo(lower)alkyl, protected carboxy(lower)alkyl, acyl(lower)alkyl, heterocyclic group or heterocyclic(lower)alkyl which may have suitable substituent(s), R 2 is aryl which may have suitable substituent(s) or heterocyclic group, and R 3 is hydrogen, lower alkoxy or arylthio, and a pharmaceutically acceptable salt thereof which are useful as a medicament.

  公式为1的杂环双环衍生物，其中：R1是苯基，可以具有适当的取代基；芳基（较低）烷基，可以具有适当的取代基；卤代（较低）烷基；保护的羧基（较低）烷基；酰基（较低）烷基；杂环基或者可以具有适当的取代基的杂环（较低）烷基；R2是苯基，可以具有适当的取代基或者杂环基；R3是氢、较低烷氧基或者芳基硫醚。它们的药物可接受盐是有用的。
• Method for the preparation of quinoline-2,3-dicarboxylic acid
  申请人：AMERICAN CYANAMID COMPANY

  公开号：EP0257433A2

  公开（公告）日：1988-03-02

  The present invention relates to novel methods for the preparation of quinoline-2,3-dicarboxylic acid, useful for the preparation of the highly effective 2-(2-imidazolin-2-yl)quinoline-3-carboxylic acid herbi­cidal agents.

  本发明涉及喹啉-2,3-二羧酸的新型制备方法，可用于制备高效的 2-(2-咪唑啉-2-基)喹啉-3-羧酸除草剂。
• Pyrido[2,3-a]pyrazine derivatives as PDE-IV and TNF inhibitors
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP0920867A1

  公开（公告）日：1999-06-09

  Heterobicyclic derivatives of formula (I) wherein R1 is aryl which may have suitable substituent(s), ar(lower)alkyl which may have suitable substituent(s), halo(lower)alkyl, protected carboxy(lower)alkyl, acyl(lower)alkyl, heterocyclic group or heterocyclic(lower)alkyl which may have suitable substituent(s), R2 is aryl which may have suitable substituent(s) or heterocyclic group, and R3 is hydrogen, lower alkoxy or arylthio, and a pharmaceutically acceptable salt thereof which are useful as PDE IV and TNF inhibitors for the treatment of hepatitis in human beings and animals.

  式(I)的杂双环衍生物 其中 R1 是芳基，可具有合适的取代基；ar(低级)烷基，可具有合适的取代基；卤代(低级)烷基；受保护的羧基(低级)烷基；酰基(低级)烷基；杂环基团或杂环(低级)烷基，可具有合适的取代基、R2 是芳基（可有适当的取代基）或杂环基，R3 是氢、低级烷氧基或芳硫基，及其药学上可接受的盐，可作为 PDE IV 和 TNF 抑制剂用于治疗人类和动物的肝炎。
• Glutarimides
  申请人：ROHM AND HAAS COMPANY

  公开号：EP0415642B1

  公开（公告）日：1995-12-06